Zelira Therapeutics

Zelira is a Global leader in Cannibinoid-based medication. Focused on developing branded cannabinoid-based medicines for the treatment of a variety of medical conditions in its Rx business, including insomnia, autism and chronic non-cancer pain.

Zed Grafix were engaged to strengthen the Zelira branding by updating the brands ID, IP and sub brands, across all mediums.

The process started with a brand review. Understanding how the current and future products would be executed with the ever so colourful logo and sub branding.

With a fresh tweak to the existing logo, we developed the dip housing to anchor this into. This allowed breathing room for sub branding.

Working within the logo colours, we developed an impactful colour palette with imagery for each sub brand/product. Each brand had its own IP that then rolled into the design across packaging, web, and marketing material.